Gedea Biotech AB
Anna-Karin Areskog is an experienced professional in quality assurance and regulatory affairs, currently serving as QA/RA director at Gedea Biotech AB. Previously, Anna-Karin worked as a senior quality and regulatory consultant at QAdvis AB and as a consultant in quality assurance at Immunovia AB. Additionally, Anna-Karin has experience as a QA specialist at Dako and as a senior quality assurance and validation engineer at ÅF.
This person is not in any teams
This person is not in any offices
Gedea Biotech AB
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.